Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Ionis Pharmaceuticals, Inc.
Ionis Pharmaceuticals Inc is the RNA-targeted drug discovery and development company. Its broad pipeline consists of close to 32 drugs to treat a wide variety of diseases with an emphasis on cardiovascular, metabolic, severe, and rare diseases.
IPO Date: December 22, 2015
Sector: Healthcare
Industry: Biotech
Market Cap: $5.67B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.89 | 1.99%
Avg Daily Range (30 D): $0.46 | 1.36%
Avg Daily Range (90 D): $0.62 | 1.99%
Institutional Daily Volume
Avg Daily Volume: 1.15M
Avg Daily Volume (30 D): 1.17M
Avg Daily Volume (90 D): 1.35M
Trade Size
Avg Trade Size (Sh.): 85
Avg Trade Size (Sh.) (30 D): 59
Avg Trade Size (Sh.) (90 D): 63
Institutional Trades
Total Inst.Trades: 10,609
Avg Inst. Trade: $2.53M
Avg Inst. Trade (30 D): $3.71M
Avg Inst. Trade (90 D): $3.24M
Avg Inst. Trade Volume: .06M
Avg Inst. Trades (Per Day): 4
Market Closing Trades
Avg Closing Trade: $5.84M
Avg Closing Trade (30 D): $8.49M
Avg Closing Trade (90 D): $8.55M
Avg Closing Volume: 135.27K
   
News
May 6, 2025 @ 5:00 PM
Angioedema Clinical Trial Pipeline Analysis Demons...
Source: Delveinsight
Mar 24, 2025 @ 12:00 PM
Praxis Precision Medicines to Present on Late-Stag...
Source: Praxis Precision Medicines, Inc.
Feb 20, 2025 @ 6:00 PM
BESREMi Achieves Strong Market Growth Amid Rising ...
Source: Delveinsight
Feb 19, 2025 @ 6:26 PM
Ionis Pharma Beats Expectations for Q4
Source: Jesterai
Feb 10, 2025 @ 3:00 PM
RNA Based Therapeutic Market Size Expected to Reac...
Source: Towards Healthcare
Financials
  TTM Q4 2024 FY 2024
Basic EPS $-.93 $-.66 $-3.04
Diluted EPS $-.93 $-.66 $-3.04
Revenue $ 131.61M $ 226.58M $ 705.14M
Gross Profit $ 130.15M $ 222.75M $ 693.92M
Net Income / Loss $ -146.94M $ -104.35M $ -453.9M
Operating Income / Loss $ -146.86M $ -110.82M $ -475.08M
Cost of Revenue $ 1.46M $ 3.83M $ 11.22M
Net Cash Flow $ 21.88M $ -92.04M $ -156.92M
PE Ratio